Gene · 8741
Papers1,439
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
161 to 180 of 1,439
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Smouldering Lesion in MS: Microglia, Lymphocytes and Pathobiochemical Mechanisms. | Int J Mol Sci | 2023 | 37628811 | PubTator, text mining | PubMed |
| Early activation of inflammatory pathways in UBA1-mutated hematopoietic stem and progenitor cells in VEXAS. | Cell Rep Med | 2023 | 37586319 | PubTator, text mining | PubMed |
| CLDN18.2 expression and its impact on prognosis and the immune microenvironment in gastric cancer. | BMC Gastroenterol | 2023 | 37582713 | PubTator, text mining | PubMed |
| Safety, Pharmacokinetics, and Pharmacodynamics of Subcutaneous Sibeprenlimab in Healthy Participants. | Clin Pharmacol Drug Dev | 2023 | 37565623 | PubTator, text mining | PubMed |
| Single-cell transcriptome analysis and protein profiling reveal broad immune system activation in IgG4-related disease. | JCI Insight | 2023 | 37561593 | PubTator, text mining | PubMed |
| TNFRSF13B gene mutation in familial acute myeloid leukemia: A new piece in the complex scenario of hereditary predisposition? | Hematol Oncol | 2023 | 37534633 | PubTator, text mining | PubMed |
| Hydroxychloroquine in nephrology: current status and future directions. | J Nephrol | 2023 | 37530940 | PubTator, text mining | PubMed |
| A Review of the Potential Benefits of Herbal Medicines, Small Molecules of Natural Sources, and Supplements for Health Promotion in Lupus Conditions. | Life (Basel) | 2023 | 37511964 | PubTator, text mining | PubMed |
| Expression of Immune-Related and Inflammatory Markers and Their Prognostic Impact in Colorectal Cancer Patients. | Int J Mol Sci | 2023 | 37511338 | PubTator, text mining | PubMed |
| Tumor Necrosis Factor-α G-308A Polymorphism and Sporadic IgA Nephropathy: A Meta-Analysis Using a Genetic Model-Free Approach. | Genes (Basel) | 2023 | 37510392 | PubTator, text mining | PubMed |
| Immunomodulatory Effects of Endoscopic Ultrasound-Guided Thermal Ablation in Patients with Pancreatic Ductal Adenocarcinoma. | Cancers (Basel) | 2023 | 37509365 | PubTator, text mining | PubMed |
| Plasma TRAIL and ANXA1 in diagnosis and prognostication of pulmonary arterial hypertension. | Pulm Circ | 2023 | 37502145 | PubTator, text mining | PubMed |
| Bi- and trispecific immune cell engagers for immunotherapy of hematological malignancies. | J Hematol Oncol | 2023 | 37501154 | PubTator, text mining | PubMed |
| Urinary Cytokines as Potential Biomarkers of Mild Cognitive Impairment and Alzheimer's Disease: A Pilot Study. | J Alzheimers Dis Rep | 2023 | 37483327 | PubTator, text mining | PubMed |
| Pansclerotic morphea is characterized by IFN-γ responses priming dendritic cell fibroblast crosstalk to promote fibrosis. | JCI Insight | 2023 | 37471168 | PubTator, text mining | PubMed |
| TNF superfamily control of tissue remodeling and fibrosis. | Front Immunol | 2023 | 37465675 | PubTator, text mining | PubMed |
| SLE Antibody-Secreting Cells Are Characterized by Enhanced Peripheral Maturation and Survival Programs. | Res Sq | 2023 | 37461641 | PubTator, text mining | PubMed |
| CSL362 potently and specifically depletes pDCs invitro and ablates SLE-immune complex-induced IFN responses. | iScience | 2023 | 37456846 | PubTator, text mining | PubMed |
| Promising Experimental Treatments for Lupus Nephritis: Key Talking Points and Potential Opportunities. | Res Rep Urol | 2023 | 37456804 | PubTator, text mining | PubMed |
| A tumor mutational burden-derived immune computational framework selects sensitive immunotherapy/chemotherapy for lung adenocarcinoma populations with different prognoses. | Front Oncol | 2023 | 37456238 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/8741/papers?page=9